Hair Kiss, the Japanese-Korean hair salon, pioneers the in-store haircut reservation app, serving nearly 80,000 customers annually.
Introducing a One-Click Haircut Reservation App for In-Store ConvenienceHONG KONG SAR - Media OutReach Newswire - 14 December 2023 - Hair Kiss...
MGI Australia unveils its CEC with DCS Lab products featuring pioneering technology in DNA, Cell, and Spatial-omics Technology
Australia first market outside China to access revolutionary new capability BRISBANE, Australia, Dec. 14, 2023 /PRNewswire/ -- MGI Australia, a subsidiary of MGI...
Guardian of Sustainable Earth: CTCI Remains a Constituent of Dow Jones Sustainability Emerging Markets Index, again Holds Construction & Engineering Leading Position
TAIPEI, Dec. 14, 2023 /PRNewswire/ -- CTCI Corporation (TWSE: 9933), a global engineering, procurement, and construction (EPC) services provider, announced today that for the...
CGTN: Role of youth highly anticipated in promoting China-Vietnam friendship
BEIJING, Dec. 14, 2023 /PRNewswire/ -- The people are the root, the lifeline and the source of strength of China-Vietnam relations, Xi Jinping, general secretary...
VENTAVR Brings VR Safety Training Solution to the World at Work Safe Asia 2023
Already leading the South Korean market, VENTA CMS leverages virtual reality to now help industrial enterprises around the world make their workplaces safer ...
Epicor Study Reveals the Evolving Role of the CFO in Driving Digital Modernization
IMG { cursor: pointer } HONG KONG SAR - Media OutReach Newswire - 14 December...
Pretty Beauty Group Leads the Beauty Tech Trend with the Introduction of LDM Triple 19
HONG KONG, Dec. 14, 2023 /PRNewswire/ -- Pretty Beauty Group once again demonstrates its commitment to leading the market by introducing a revolutionary beauty...
Abbisko Therapeutics Announces that U.S. FDA Has Granted Fast Track Designation for Its CSF-1R Inhibitor Pimicotinib (ABSK021)
SHANGHAI, Dec. 14, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") today announced that its CSF-1R inhibitor pimicotinib (ABSK021) has been granted the fast track...
